NCT07050875View on ClinicalTrials.gov

Clinical Investigation to Validate the Safety and Performance of the ABLE Exoskeleton Device for Individuals With Acquired Brain Injury in a Clinical Setting

NARecruitingINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

June 30, 2025

Primary Completion Date

October 31, 2025

Study Completion Date

October 31, 2025

Conditions
Acquired Brain Injury (Including Stroke)
Interventions
DEVICE

ABLE Exoskeleton

Participants will undergo a 10-session gait training program with the exoskeleton, twice a week for up to 6 weeks. Each session will last 60 minutes.

Trial Locations (3)

15174

RECRUITING

Cefine Neurología (CEFINE), Culleredo

28023

RECRUITING

Centro Europeo de Neurociencias (CEN), Madrid

08908

RECRUITING

Fundación Step by Step, L'Hospitalet de Llobregat

All Listed Sponsors
collaborator

Centro Europeo de Neurociencias (CEN)

UNKNOWN

collaborator

Cefine Neurología (CEFINE)

UNKNOWN

collaborator

Fundación Step by Step (SBS)

UNKNOWN

lead

ABLE Human Motion S.L.

INDUSTRY

NCT07050875 - Clinical Investigation to Validate the Safety and Performance of the ABLE Exoskeleton Device for Individuals With Acquired Brain Injury in a Clinical Setting | Biotech Hunter | Biotech Hunter